Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 16Recruiting 7Unknown 5Terminated 4Withdrawn 3Not yet recruiting 3Active not recruiting 2Enrolling by invitation 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Neoplasms 2Lung Neoplasms 2Pleural Neoplasms 1Mesothelioma 1Lymphoma, Follicular 1Glioma 1Glioblastoma 1Dementia 1Cognitive Dysfunction 1Brain Neoplasms 1Astrocytoma 1Alzheimer Disease 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Drug Delivery Systems × Clear all
NCT05673759 2025-12-16

Event-Related Potential (ERP) Components in Clinical Diagnosis

Boston University

Terminated
148 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT00748085 2015-07-23

ICEtheMAD

CSA Medical, Inc.

Phase NA Terminated
5 enrolled 5 charts
Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT00747916 2015-07-16

Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS")

CSA Medical, Inc.

Phase 4 Terminated
3 enrolled 6 charts
Thoracic

Lung Neoplasms, Neoplasms, Pleural Neoplasms

NCT00761280 2014-11-14

SAPPHIRE

Isarna Therapeutics GmbH

Phase 3 Terminated
27 enrolled 28 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡